Used primarily in research settings, this compound is known for its ability to inhibit neutrophil elastase, an enzyme involved in tissue degradation during inflammatory responses. It has been investigated for potential therapeutic applications in conditions characterized by excessive inflammation and tissue damage, such as acute lung injury, chronic obstructive pulmonary disease (COPD), and other inflammatory disorders. By blocking elastase activity, it helps reduce the breakdown of connective tissues and may mitigate disease progression in experimental models. Its use remains largely experimental, with studies focusing on understanding its efficacy and safety profile in modulating inflammatory pathways.